Baricitinib impurity 5

SL-2805

Baricitinib impurity 5, >96%

IUPAC Name : 2-(3-(4-(4-(1-(3-(Cyanomethyl)-1-(ethylsulfonyl)azetidin-3-yl)-1H-pyrazol-4-yl)-7H-pyrrolo[2,3-d]pyrimidin-2-yl)-1H-pyrazol-1-yl)-1-(ethylsulfonyl)azetidin-3-yl)acetonitrile

Price And Availability
Pack Size	Price in USD	Add To Shopping Cart	Availability	Shipping Status
5MG	Request A Quote		Back Order	Estimated to ship on 04 October 2026
10MG	Request A Quote		Back Order	Estimated to ship on 04 October 2026
25MG	Request A Quote		Back Order	Estimated to ship on 04 October 2026

Applications : This is an impurity of Baricitinib, which is a selective and orally bioavailable JAK1 and JAK2 inhibitor for the treatment of rheumatoid arthritis. Also, this is a COVID-19 related research chemical.

References : Fridman J. S. et al. J. Immunol., 184(9), 5298-5307, 2010; Jabbari A. et al. EBioMedicine. 2(4), 351-5, 2015; Khan I. M. et al. Int. J. Obes (Lond). 39(11), 1607-1618, 2015.

Storage : Keep container tightly closed under nitrogen or argon and refrigerate for long-term shelf life.

Caution : In case of contact with skin or eyes, rinse immediately with plenty of water and seek medical advice. Wear suitable protective clothing and gloves.